Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

0.505
Delayed Data
As of Feb 09
 -0.005 / -0.98%
Today’s Change
0.40
Today|||52-Week Range
4.26
-53.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues5.3M3.2M5.9M5.9M
 
 
 
 
 
Cost of Goods Sold3.6M2.8M5.2M4.2M
 
 
 
 
 
Depreciation And Amortization608.6K604.4K649.9K638.7K
 
 
 
 
 
 
Operating ExpensesGross Income1.0M-268.4K-8.4K1.0M
 
 
 
 
 
General Expenses16.6M17.8M16.3M11.4M
 
 
 
 
 
Research And Development10.1M6.8M7.6M6.3M
 
 
 
 
 
Total Operating Expenses20.8M21.3M22.1M16.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.6M-18.1M-16.3M-10.4M
 
 
 
 
 
Extraordinary Credit4.2M--5.4M0.00
 
 
 
Extraordinary Charge---550.0K-9.4M-420.0K
 
 
 
 
Interest Expense On Debt372.2K551.0K547.3K553.0K
 
 
 
 
 
Other Expenses-181.4K4.0K4.8K9.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.9M-19.2M-20.9M-11.3M
 
 
 
 
 
Income Taxes-246.4K-46.6K-3.7M-46.6K
 
 
 
 
 
Minority Interest-78.4K-44.6K-31.8K-16.9K
 
 
 
 
 
Net Income-11.6M-19.2M-17.1M-11.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.3M37.6M44.6M55.2M
 
 
 
 
 
Shares To Calculate EPS Diluted36.3M37.6M44.6M55.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.32-$0.51-$0.38-$0.21
 
 
 
 
 
EPS Diluted-$0.32-$0.51-$0.38-$0.21